Vasopeptidase inhibition: A new direction in cardiovascular treatment
- 作者Jordan R. Asher; Allen J. Naftilan
- 卷第2卷
- 期第4期
- 印刷ISSN1522-6417
- 电子ISSN1534-3111
- 文件大小388.71KB
- 发表时间2000
- DOI10.1007/s11906-000-0042-y
- 页码384-391
Spironolactone in the management of congestive heart failureJames E. Muller · 1990
Spironolactone in the Management of Congestive Heart FailureSteven R. Kayser · 2000
Spironolactone reduced mortality in severe congestive heart failureHenderson, M. · Evidence-Based Medicine · 2000
Spironolactone in the Treatment of Congestive Heart FailureLloyd, Stanley J; Mauro, Vincent F · The Annals of Pharmacotherapy · 2000
IS THE ADDITION OF SPIRONOLACTONE NECESSARY IN CONGESTIVE HEART FAILURE?Inpharma Weekly · 1977
Diuretic therapy in congestive heart failure – new aspects regarding spironolactone therapyHaller, · Therapeutische Umschau · 2000
Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactoneCruz, C. S. · Nephrology Dialysis Transplantation · 2003